SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000849146-17-000014
Filing Date
2017-02-08
Accepted
2017-02-08 16:06:09
Documents
44
Period of Report
2016-12-31

Document Format Files

Seq Description Document Type Size
1 10-Q lfvn_123116x10q.htm 10-Q 725845
2 EXHIBIT 10.1 lfvn_123116xex101.htm EX-10.1 66675
3 EXHIBIT 31.1 lfvn_123116xex311.htm EX-31.1 11555
4 EXHIBIT 31.2 lfvn_123116xex312.htm EX-31.2 11537
5 EXHIBIT 32.1 lfvn_123116xex321.htm EX-32.1 5686
6 EXHIBIT 32.2 lfvn_123116xex322.htm EX-32.2 5668
  Complete submission text file 0000849146-17-000014.txt   3342612

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT lfvn-20161231.xml EX-101.INS 453254
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT lfvn-20161231.xsd EX-101.SCH 27615
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT lfvn-20161231_cal.xml EX-101.CAL 51276
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT lfvn-20161231_def.xml EX-101.DEF 109072
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT lfvn-20161231_lab.xml EX-101.LAB 416928
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT lfvn-20161231_pre.xml EX-101.PRE 218269
Mailing Address 9785 S. MONROE STREET SUITE 300 SANDY UT 84070
Business Address 9785 S. MONROE STREET SUITE 300 SANDY UT 84070 801-432-9000
Lifevantage Corp (Filer) CIK: 0000849146 (see all company filings)

IRS No.: 841097796 | State of Incorp.: CO | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-35647 | Film No.: 17582572
SIC: 2834 Pharmaceutical Preparations